In addition, Wu et al. has demonstrated that miR-30s could regulate Ca2+/CaN signaling in cardiomyocytes [36], which indicates that other miRNAs may be also potential targets for the treatment of myocardial hypertrophy and need further investigate in the future research. The gene discussed is NUP214; the disease is cardiac hypertrophy.